Koslowski M

Department of Psychiatry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

9 papers · ORCID

ArticlePsychedelics

Personality changes following first-time psychedelic use in college students in Germany.

Volkmann C, Seitz M, Evens R +3

Europe PMC2026
ArticlePsilocybin

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Mertens LJ, Betzler F, Brand M +24

Europe PMC2026
ArticlePsilocybin

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Mertens LJ, Koslowski M, Betzler F +23

Europe PMC2026
ArticlePsychedelics

Guiding Through Challenging Psychedelic Experiences and "Bad Trips".

Koslowski M, Gasser P

Europe PMC2026
ArticlePsilocybin

Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.

Viljoen G, Walter H, Bendau A +2

Europe PMC2026
ArticlePsilocybin

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Yaden DB, Graziosi M, Owen AM +39

Europe PMC2025
ArticlePsychedelics

Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research.

Koslowski M, de Haas MP, Fischmann T

Europe PMC2023
ArticlePsilocybin

Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.

Mertens LJ, Koslowski M, Betzler F +9

Europe PMC2022
ArticlePsilocybin

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.

Wolff M, Evens R, Mertens LJ +4

Europe PMC2020